Cost-Effectiveness Analysis of the Bivalent Compared With the Quadrivalent Human Papillomavirus Vaccines in Taiwan

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.02.012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Comparative Cost-Consequence Analysis of the Bivalent and Quadrivalent Vaccines Against HPV in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Cost-Effectiveness of Quadrivalent Human Papillomavirus Vaccination in Adolescent Girls in Russian Federation

Pediatric pharmacology
2017English

Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccines for Children

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Quadrivalent HPV Vaccine in Argentina: Cost-Effectiveness Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Cost-Effectiveness Analysis of Female Human Papillomavirus Vaccination in Mainland China

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model

PLoS ONE
Multidisciplinary
2015English

Cost-Effectiveness of the Next Generation Nonavalent Human Papillomavirus Vaccine in the Context of Primary Human Papillomavirus Screening in Australia: A Comparative Modelling Analysis

The Lancet Public Health
EnvironmentalPublic HealthOccupational Health
2016English

Cost-Effectiveness of Two-Dose Human Papillomavirus Vaccination in Singapore

Singapore Medical Journal
Medicine
2018English

Pin67 - Cost-Effectiveness of Quadrivalent Influenza Vaccination in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy